top of page

Board Transitions: Thank You, Drs. Baratz, Cameron, and Lee

On December 31, three long-serving American Board of Ophthalmology Directors will complete their eight-year terms:

Keith H. Baratz, M.D., joined the ABO in 2010. Over the years, he participated in numerous committees, most notably leading efforts to develop Practice Improvement Modules (PIMs) on the MOC Part IV Subcommittee and chairing the MOC Committee since 2016. A professor of ophthalmology and cornea specialist at Mayo Clinic in Rochester, MN, Dr. Baratz earned a medical degree at Duke University, completed residency training at Mayo Clinic, and returned to Duke for a fellowship in cornea and external eye diseases.

J. Douglas Cameron, M.D., MBA, leaves the ABO after serving as chair of the Examiners Committee, which oversees the recruitment and development of ABO volunteers. Dr. Cameron is a professor in the Department of Ophthalmology and Visual Neurosciences at the University of Minnesota and director of research. He earned a medical degree from Northwestern University Feinberg School of Medicine, completed residency training at Scheie Eye Institute at the University of Pennsylvania, and engaged in fellowships in ophthalmic pathology at Scheie Eye and the Armed Forces Institute of Pathology. Dr. Cameron also holds a master’s degree in Business Administration from the University of St. Thomas in Minneapolis, MN.

Paul P. Lee, M.D., J.D., is the outgoing chair of the ABO. As a director of the board, Dr. Lee oversaw the CEO Search Committee in 2016 and participated in organizing the ABO’s 100th anniversary symposium. He contributed to the work of the Finance, Conflict of Interest, and Examiners Committees and led collaboration efforts between the ABO and American Academy of Ophthalmology resulting in the development of the IRIS® Registry-based practice improvement project pathway. Recently elected to the National Academy of Medicine, Dr. Lee is the F. Bruce Fralick Professor and chair of the University of Michigan Department of Ophthalmology and Visual Sciences. He is a glaucoma specialist and director of the W.K. Kellogg Eye Center.

In 2018, Dr. Ann W. Warn begins her first term as a Director of the ABO.

Recent Posts

See All

Measuring What We Do: The ABO Scorecard

The American Board of Ophthalmology’s primary responsibility, as summarized in its mission and guiding principles, is to the public. To help track progress toward key initiatives, the ABO uses a score

bottom of page